Pharmacoeconomic evaluation of the use of targeted therapy and chemotherapy in the first- and second-line therapies for metastatic colorectal cancer

Por A. A. Tryakin, P. A. Balunov
Publicado em 2018-11-01

Treatment of early (I, IIA/B) stages of germinomas of the testis

Por A. A. Tryakin, A. A. Bulanov, S. A. Tyulyandin
Publicado em 2006-12-01

BIOLOGICAL MARKERS OF RECTAL CANCER NEOADJUVANT CHEMORADIOTHERAPY EFFICACY

Por M. Yu. Fedyanin, A. A. Tryakin, S. A. Tjulandin
Publicado em 2015-02-01

Localization of the primary tumor of the colon: аre there essential differences?

Por M. Yu. Fedyanin, A. A. Tryakin, S. A. Tjulandin
Publicado em 2017-12-01

Role of microsatellite instability in colon cancer

Por M. Yu. Fedyanin, A. A. Tryakin, S. A. Tjulandin
Publicado em 2015-02-01

CHOICE OF TARGETED DRUG FOR SECOND-LINE METASTATIC COLON CANCER CHEMOTHERAPY

Por M. Yu. Fedyanin, A. A. Tryakin, S. A. Tjulandin
Publicado em 2015-05-01

Does asymptomatic primary tumor need to be removed in unresectable metastatic colon cancer?

Por M. Yu. Fedyanin, A. A. Tryakin, S. A. Tyulyandin
Publicado em 2015-10-01

FIRST-LINE TREATMENT IN PATIENTS WITH INOPERABLE METASTATIC COLON CANCER

Por M. Yu. Fedyanin, A. A. Tryakin, S. A. Tjulandin
Publicado em 2015-02-01

Efficacy of continuing anti-angiogenic agents in the second-line treatment for metastatic colon cancer depending on the KRAS mutation status: a meta-analysis

Por M. Yu. Fedyanin, A. A. Tryakin, S. A. Tjulandin
Publicado em 2018-07-01

PROMISES FOR TREATING COLON CANCER PATIENTS WITH BRAF GENE MUTATION

Por M. Yu. Fedyanin, A. A. Tryakin, S. A. Tjulandin
Publicado em 2015-02-01

ADJUVANT CHEMOTHERAPY AFTER RECTAL CANCER CHEMORADIOTHERAPY

Por M. Yu. Fedyanin, A. A. Tryakin, S. A. Tjulandin
Publicado em 2015-02-01

Colorectal cancer, screening: achievements и opportunities

Por E. A. Polyanskaya, M. Yu. Fedyanin, A. A. Tryakin, S. A. Tjulandin
Publicado em 2018-12-01

Meta-analysis of clinical trials on concordance of mutational stauts of primary tumour and distant metastases of colorectal cancer

Por M. Yu. Fedyanin, A. A. Tryakin, I. A. Pokataev, S. A. Tyulyandin
Publicado em 2017-04-01

CHEMOTHERAPY IN THE MANAGEMENT OF LOCALIZED AND METASTATIC COLON CANCER: NEW AND YET UNFORGOTTEN APPROACHES

Por N. V. Dobrova, O. O. Gordeeva, E. V. Chernoglazova, A. A. Tryakin
Publicado em 2017-11-01

Some aspects of immunotherapy in colon cancer

Por M. Yu. Fedyanin, Kh. Kh.-M. El’snukaeva, A. A. Tryakin, S. A. Tyulyandin
Publicado em 2018-05-01

Effect of cancer drugs in patients with metastatic colorectal cancer in terms of mortality reduction

Por M. Yu. Fedyanin, I. A. Pokataev, O. V. Sekhina, A. A. Tryakin, S. A. Tjulandin
Publicado em 2017-12-01

Late complications of the treatment of patients with germ cell tumors

Por D. G. Danielyan, A. A. Salimova, A. A. Bulanov, M. Yu. Fedyanin, A. A. Tryakin
Publicado em 2020-06-01

TREATMENT FOR STAGE I TESTICULAR SEMINOMA

Por E. A. Burova, A. A. Bulanov, A. A. Tryakin, M. Yu. Fedyanin, S. A. Tyulyandin, V. B. Matveyev
Publicado em 2010-09-01

TREATMENT FOR STAGE I NONSEMINOMATOUS TESTICULAR GERM CELL TUMORS

Por E. A. Burova, A. A. Bulanov, A. A. Tryakin, M. Yu. Fedyanin, V. B. Matveev, S. A. Tulandin
Publicado em 2011-03-01

OVARIAN DYSGERMINOMAS: TREATMENT EXPERIENCE OF THE N.N.BLOKHIN CRC RAMS

Por O. N. Streltzova, M. Yu. Fedyanin, A. A. Tryakin, A. A. Bulanov, V. V. Zhordania, S. A. Tyulandin
Publicado em 2014-09-01